Paris, France

Xavier Treton

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 6.2

ph-index = 1


Company Filing History:


Years Active: 2015-2021

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Xavier Treton in Predicting and Treating Inflammatory Bowel Diseases

Introduction

Xavier Treton is a notable inventor based in Paris, France, recognized for his contributions to the field of medical research, particularly in the treatment of inflammatory bowel diseases. With a total of three patents to his name, Treton has developed innovative methods that aim to improve patient outcomes in this challenging area of healthcare.

Latest Patents

Treton's latest patents include groundbreaking methods for predicting treatment responses in patients with acute severe colitis. His invention provides the first prediction tool for responses to first- and second-line treatments in acute severe ulcerative colitis. By identifying putative mRNA targets of dysregulated microRNAs from patient biopsies, Treton's work has achieved a prediction accuracy of 96.6% for discriminating responders from non-responders to steroids. Additionally, he has developed algorithms to classify responders to infliximab and cyclosporine based on mucosal microRNA expression levels.

Another significant patent involves methods and pharmaceutical compositions for treating inflammatory bowel diseases using agonists of the orexin-1 receptor. This innovative approach offers a new therapeutic avenue for patients suffering from these conditions, highlighting Treton's commitment to advancing medical science.

Career Highlights

Throughout his career, Xavier Treton has worked with esteemed institutions such as the National Institute of Health and Medical Research and the University of Paris. His research has significantly contributed to the understanding and treatment of inflammatory bowel diseases, showcasing his expertise and dedication to improving patient care.

Collaborations

Treton has collaborated with notable colleagues in the field, including Eric Ogier-Denis and Yoram Bouhnik. These partnerships have further enriched his research and innovations, leading to impactful advancements in medical treatments.

Conclusion

Xavier Treton's innovative work in predicting and treating inflammatory bowel diseases demonstrates his significant contributions to medical research. His patents reflect a commitment to enhancing patient outcomes through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…